{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:58:18Z","timestamp":1779296298298,"version":"3.51.4"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12033-023-00821-z","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T07:02:15Z","timestamp":1691996535000},"page":"1853-1871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Coding Therapeutic Nucleic Acids from Recombinant Proteins to Next-Generation Vaccines: Current Uses, Limitations, and Future Horizons"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-4421","authenticated-orcid":false,"given":"Gamaleldin I.","family":"Harisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek M.","family":"Faris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman Y.","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyad F.","family":"Alzhrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neveen A.","family":"Kohaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fars K.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"issue":"1","key":"821_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0450-0","volume":"9","author":"JC Kaczmarek","year":"2017","unstructured":"Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017). Advances in the delivery of RNA therapeutics: From concept to clinical reality. Genome Medicine, 9(1), 1\u201316.","journal-title":"Genome Medicine"},{"issue":"11","key":"821_CR2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021). mRNA vaccines for infectious diseases: Principles, delivery and clinical translation. Nature Reviews Drug Discovery., 20(11), 817\u2013838.","journal-title":"Nature Reviews Drug Discovery."},{"issue":"6","key":"821_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00232-019-00082-5","volume":"252","author":"GI Harisa","year":"2019","unstructured":"Harisa, G. I., & Faris, T. M. (2019). Direct drug targeting into intracellular compartments: Issues, limitations, and future outlook. The Journal of Membrane Biology, 252(6), 527\u2013539.","journal-title":"The Journal of Membrane Biology"},{"key":"821_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-94-017-8739-0_5","volume-title":"Nanomaterial","author":"IM Adjei","year":"2014","unstructured":"Adjei, I. M., Sharma, B., & Labhasetwar, V. (2014). Nanoparticles: cellular uptake and cytotoxicity. In D. G. Capco & Y. Chen (Eds.), Nanomaterial (pp. 73\u201391). Springer."},{"key":"821_CR5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fphar.2020.00629","volume":"11","author":"A Kumar","year":"2020","unstructured":"Kumar, A., Ahmad, A., Vyawahare, A., & Khan, R. (2020). Membrane trafficking and subcellular drug targeting pathways. Frontiers in Pharmacology, 11, 629.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"821_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-1804-8","volume":"17","author":"L Van Hoecke","year":"2019","unstructured":"Van Hoecke, L., & Roose, K. (2019). How mRNA therapeutics are entering the monoclonal antibody field. Journal of Translational Medicine, 17(1), 1\u201314.","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"821_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02402-z","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard, S., Abak, A., Baniahmad, A., Hussen, B. M., Taheri, M., Jamali, E., et al. (2022). Interaction between non-coding RNAs, mRNAs and G-quadruplexes. Cancer Cell International, 22(1), 1\u201311.","journal-title":"Cancer Cell International"},{"issue":"5","key":"821_CR8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrm3105","volume":"12","author":"KS Matlin","year":"2011","unstructured":"Matlin, K. S. (2011). Spatial expression of the genome: The signal hypothesis at forty. Nature Reviews Molecular Cell Biology, 12(5), 333\u2013340.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"821_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fbioe.2021.628137","volume":"9","author":"TR Damase","year":"2021","unstructured":"Damase, T. R., Sukhovershin, R., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021). The limitless future of RNA therapeutics. Frontiers in Bioengineering and Biotechnology, 9, 161.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"1","key":"821_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"H Lu","year":"2020","unstructured":"Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., et al. (2020). Recent advances in the development of protein\u2013protein interactions modulators: Mechanisms and clinical trials. Signal Transduction and Targeted Therapy, 5(1), 1\u201323.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"821_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","volume":"19","author":"E Tambuyzer","year":"2020","unstructured":"Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., et al. (2020). Therapies for rare diseases: Therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery., 19(2), 93\u2013111.","journal-title":"Nature Reviews Drug Discovery."},{"issue":"10","key":"821_CR12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/14712598.2015.1069271","volume":"15","author":"M Dicker","year":"2015","unstructured":"Dicker, M., & Strasser, R. (2015). Using glyco-engineering to produce therapeutic proteins. Expert Opinion on Biological Therapy., 15(10), 1501\u20131516.","journal-title":"Expert Opinion on Biological Therapy."},{"issue":"2","key":"821_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0928-0987(01)00222-6","volume":"15","author":"G Walsh","year":"2002","unstructured":"Walsh, G. (2002). Biopharmaceuticals and biotechnology medicines: An issue of nomenclature. European Journal of Pharmaceutical Sciences., 15(2), 135\u2013138.","journal-title":"European Journal of Pharmaceutical Sciences."},{"issue":"4","key":"821_CR14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","volume":"9","author":"M Schenone","year":"2013","unstructured":"Schenone, M., Dan\u010d\u00edk, V., Wagner, B. K., & Clemons, P. A. (2013). Target identification and mechanism of action in chemical biology and drug discovery. Nature Chemical Biology, 9(4), 232\u2013240.","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"821_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., et al. (2020). Therapeutic siRNA: State of the art. Signal Transduction and Targeted Therapy, 5(1), 1\u201325.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"6","key":"821_CR16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., et al. (2021). The current landscape of nucleic acid therapeutics. Nature Nanotechnology, 16(6), 630\u2013643.","journal-title":"Nature Nanotechnology"},{"issue":"8","key":"821_CR17","doi-asserted-by":"crossref","first-page":"2001812","DOI":"10.1002\/adhm.202001812","volume":"10","author":"W Ho","year":"2021","unstructured":"Ho, W., Gao, M., Li, F., Li, Z., Zhang, X. Q., & Xu, X. (2021). Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery. Advanced Healthcare Materials, 10(8), 2001812.","journal-title":"Advanced Healthcare Materials"},{"issue":"15","key":"821_CR18","doi-asserted-by":"crossref","first-page":"E3351","DOI":"10.1073\/pnas.1720542115","volume":"115","author":"M Yanez Arteta","year":"2018","unstructured":"Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., et al. (2018). Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proceedings of the National Academy of Sciences, 115(15), E3351\u2013E3360.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"821_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","volume":"65","author":"N Pardi","year":"2020","unstructured":"Pardi, N., Hogan, M. J., & Weissman, D. (2020). Recent advances in mRNA vaccine technology. Current Opinion in Immunology, 65, 14\u201320.","journal-title":"Current Opinion in Immunology"},{"issue":"18","key":"821_CR20","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.3390\/ijms21186582","volume":"21","author":"S Xu","year":"2020","unstructured":"Xu, S., Yang, K., Li, R., & Zhang, L. (2020). mRNA vaccine era\u2014Mechanisms, drug platform and clinical prospection. International Journal of Molecular Sciences, 21(18), 6582.","journal-title":"International Journal of Molecular Sciences"},{"key":"821_CR21","volume":"178","author":"A Gupta","year":"2021","unstructured":"Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021). Nucleic acid delivery for therapeutic applications. Advanced Drug Delivery Reviews, 178, 113834.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"821_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102509","volume":"296","author":"B Dutta","year":"2021","unstructured":"Dutta, B., Barick, K., & Hassan, P. (2021). Recent advances in active targeting of nanomaterials for anticancer drug delivery. Advances in Colloid and Interface Science, 296, 102509.","journal-title":"Advances in Colloid and Interface Science"},{"issue":"4","key":"821_CR23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/21691401.2017.1354301","volume":"46","author":"GI Harisa","year":"2018","unstructured":"Harisa, G. I., Badran, M. M., Alanazi, F. K., & Attia, S. M. (2018). An overview of nanosomes delivery mechanisms: Trafficking, orders, barriers and cellular effects. Artificial Cells, Nanomedicine, and Biotechnology, 46(4), 669\u2013679.","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"issue":"5","key":"821_CR24","first-page":"1","volume":"21","author":"GI Harisa","year":"2020","unstructured":"Harisa, G. I., Sherif, A. Y., Youssof, A. M., Alanazi, F. K., & Salem-Bekhit, M. M. (2020). Bacteriosomes as a promising tool in biomedical applications: Immunotherapy and drug delivery. An Official Journal of the American Association of Pharmaceutical Scientists, 21(5), 1\u201313.","journal-title":"An Official Journal of the American Association of Pharmaceutical Scientists"},{"issue":"6","key":"821_CR25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00232-017-0003-x","volume":"250","author":"GI Harisa","year":"2017","unstructured":"Harisa, G. I., Badran, M. M., Alanazi, F. K., & Attia, S. M. (2017). Crosstalk of nanosystems induced extracellular vesicles as promising tools in biomedical applications. The Journal of Membrane Biology., 250(6), 605\u2013616.","journal-title":"The Journal of Membrane Biology."},{"issue":"4","key":"821_CR26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/pr.120.019554","volume":"72","author":"A-M Yu","year":"2020","unstructured":"Yu, A.-M., Choi, Y. H., & Tu, M.-J. (2020). RNA drugs and RNA targets for small molecules: Principles, progress, and challenges. Pharmacological Reviews, 72(4), 862\u2013898.","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"821_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12551-017-0392-1","volume":"10","author":"T Ahmadzada","year":"2018","unstructured":"Ahmadzada, T., Reid, G., & McKenzie, D. R. (2018). Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophysical Reviews, 10(1), 69\u201386.","journal-title":"Biophysical Reviews"},{"key":"821_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2016.03.022","volume":"229","author":"SN Tammam","year":"2016","unstructured":"Tammam, S. N., Azzazy, H. M., & Lamprecht, A. (2016). How successful is nuclear targeting by nanocarriers? Journal of Controlled Release, 229, 140\u2013153.","journal-title":"Journal of Controlled Release"},{"issue":"8","key":"821_CR29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tcb.2017.03.002","volume":"27","author":"J Neefjes","year":"2017","unstructured":"Neefjes, J., Jongsma, M. M., & Berlin, I. (2017). Stop or go? Endosome positioning in the establishment of compartment architecture, dynamics, and function. Trends in Cell Biology, 27(8), 580\u2013594.","journal-title":"Trends in Cell Biology"},{"issue":"1","key":"821_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","volume":"8","author":"L Kou","year":"2013","unstructured":"Kou, L., Sun, J., Zhai, Y., & He, Z. (2013). The endocytosis and intracellular fate of nanomedicines: Implication for rational design. Asian Journal of Pharmaceutical Sciences, 8(1), 1\u201310.","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"821_CR31","unstructured":"Escape, E., Prater, A. R., Pellois J.-P. (2023). 10.1 Endosomal Escape 10.1. 1 Introduction Cell-penetrating peptides (CPPs) are peptides that can enter the cytoplasm of cells. Through direct conjugation or coincubation methods, they can allow the cytosolic delivery of a variety of molecular payloads. While the process of cellular delivery has. Cell-Penetrating Peptides: Design, Development and Applications."},{"issue":"3","key":"821_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0854.2005.00268.x","volume":"6","author":"IK Poon","year":"2005","unstructured":"Poon, I. K., & Jans, D. A. (2005). Regulation of nuclear transport: Central role in development and transformation? Traffic, 6(3), 173\u2013186.","journal-title":"Traffic"},{"issue":"5470","key":"821_CR33","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.288.5470.1374","volume":"288","author":"SR Wente","year":"2000","unstructured":"Wente, S. R. (2000). Gatekeepers of the nucleus. Science, 288(5470), 1374\u20131377.","journal-title":"Science"},{"issue":"4","key":"821_CR34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2004.10.004","volume":"57","author":"M Belting","year":"2005","unstructured":"Belting, M., Sandgren, S., & Wittrup, A. (2005). Nuclear delivery of macromolecules: Barriers and carriers. Advanced Drug Delivery Reviews, 57(4), 505\u2013527.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"821_CR35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/B978-0-12-386043-9.00006-2","volume":"287","author":"T Jamali","year":"2011","unstructured":"Jamali, T., Jamali, Y., Mehrbod, M., & Mofrad, M. (2011). Nuclear pore complex: Biochemistry and biophysics of nucleocytoplasmic transport in health and disease. International Review of Cell and Molecular Biology, 287, 233\u2013286.","journal-title":"International Review of Cell and Molecular Biology"},{"issue":"1\u20133","key":"821_CR36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejps.2009.11.010","volume":"39","author":"R Misra","year":"2010","unstructured":"Misra, R., & Sahoo, S. K. (2010). Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. European Journal of Pharmaceutical Sciences, 39(1\u20133), 152\u2013163.","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"821_CR37","first-page":"29","volume-title":"Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins. Site-Specific Protein Labeling","author":"NJ Yang","year":"2015","unstructured":"Yang, N. J., & Hinner, M. J. (2015). Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins. Site-Specific Protein Labeling (pp. 29\u201353). Springer."},{"issue":"1","key":"821_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/dvdy.20569","volume":"235","author":"CA Hogarth","year":"2006","unstructured":"Hogarth, C. A., Calanni, S., Jans, D. A., & Loveland, K. L. (2006). Importin \u03b1 mRNAs have distinct expression profiles during spermatogenesis. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 235(1), 253\u2013262.","journal-title":"Developmental Dynamics: An Official Publication of the American Association of Anatomists"},{"issue":"5","key":"821_CR39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.nantod.2011.08.002","volume":"6","author":"JG Huang","year":"2011","unstructured":"Huang, J. G., Leshuk, T., & Gu, F. X. (2011). Emerging nanomaterials for targeting subcellular organelles. Nano Today, 6(5), 478\u2013492.","journal-title":"Nano Today"},{"issue":"1","key":"821_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2897","volume":"9","author":"L Rajendran","year":"2010","unstructured":"Rajendran, L., Kn\u00f6lker, H.-J., & Simons, K. (2010). Subcellular targeting strategies for drug design and delivery. Nature Reviews Drug discovery, 9(1), 29\u201342.","journal-title":"Nature Reviews Drug discovery"},{"issue":"1","key":"821_CR41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425247.2015.1086745","volume":"13","author":"A Jhaveri","year":"2016","unstructured":"Jhaveri, A., & Torchilin, V. (2016). Intracellular delivery of nanocarriers and targeting to subcellular organelles. Expert Opinion on Drug Delivery, 13(1), 49\u201370.","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"1","key":"821_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/17425240903380446","volume":"7","author":"S Kim","year":"2010","unstructured":"Kim, S., Shi, Y., Kim, J. Y., Park, K., & Cheng, J.-X. (2010). Overcoming the barriers in micellar drug delivery: Loading efficiency, in vivo stability, and micelle\u2013cell interaction. Expert Opinion on Drug Delivery, 7(1), 49\u201362.","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"10","key":"821_CR43","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/0929867013372391","volume":"8","author":"J Micklefield","year":"2001","unstructured":"Micklefield, J. (2001). Backbone modification of nucleic acids: Synthesis, structure and therapeutic applications. Current Medicinal Chemistry, 8(10), 1157\u20131179.","journal-title":"Current Medicinal Chemistry"},{"issue":"7","key":"821_CR44","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1021\/acsnano.5b01320","volume":"9","author":"M Yu","year":"2015","unstructured":"Yu, M., & Zheng, J. (2015). Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano, 9(7), 6655\u20136674.","journal-title":"ACS Nano"},{"key":"821_CR45","doi-asserted-by":"crossref","first-page":"114417","DOI":"10.1016\/j.addr.2022.114417","volume":"188","author":"T Nakamura","year":"2022","unstructured":"Nakamura, T., Sato, Y., Yamada, Y., Abd Elwakil, M. M., Kimura, S., Younis, M. A., et al. (2022). Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines. Advanced Drug Delivery Reviews, 188, 114417.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"821_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.00015.2016","volume":"97","author":"W Sun","year":"2017","unstructured":"Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017). Leveraging physiology for precision drug delivery. Physiological Reviews, 97(1), 189\u2013225.","journal-title":"Physiological Reviews"},{"issue":"15","key":"821_CR47","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/1389450120666190715104100","volume":"20","author":"AY Sherif","year":"2019","unstructured":"Sherif, A. Y., Harisa, G. I., Alanazi, F. K., & Youssof, A. M. (2019). Engineering of exosomes: Steps towards green production of drug delivery system. Current Drug Targets, 20(15), 1537\u20131549.","journal-title":"Current Drug Targets"},{"key":"821_CR48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2019.04.040","volume":"458","author":"AJ Mukalel","year":"2019","unstructured":"Mukalel, A. J., Riley, R. S., Zhang, R., & Mitchell, M. J. (2019). Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy. Cancer Letters, 458, 102\u2013112.","journal-title":"Cancer Letters"},{"key":"821_CR49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102916","volume":"66","author":"M Bilal","year":"2021","unstructured":"Bilal, M., Qindeel, M., Raza, A., Mehmood, S., & Rahdar, A. (2021). Stimuli-responsive nanoliposomes as prospective nanocarriers for targeted drug delivery. Journal of Drug Delivery Science and Technology, 66, 102916.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"821_CR50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1201\/b22463","volume-title":"Dendrimers for Drug Delivery","author":"PA Sharma","year":"2018","unstructured":"Sharma, P. A., Maheshwari, R., Tekade, M., Shrivastava, S. K., Chauhan, A. S., & Tekade, R. K. (2018). Dendrimers in gene delivery. In A. K. Sharma & R. K. Keservani (Eds.), Dendrimers for Drug Delivery (pp. 274\u2013328). Apple Academic Press."},{"issue":"2","key":"821_CR51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2009.06.008","volume":"139","author":"H Hatakeyama","year":"2009","unstructured":"Hatakeyama, H., Ito, E., Akita, H., Oishi, M., Nagasaki, Y., Futaki, S., et al. (2009). A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. Journal of Controlled Release, 139(2), 127\u2013132.","journal-title":"Journal of Controlled Release"},{"issue":"4","key":"821_CR52","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1021\/bc700448h","volume":"19","author":"EJ Kwon","year":"2008","unstructured":"Kwon, E. J., Bergen, J. M., & Pun, S. H. (2008). Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjugate Chemistry, 19(4), 920\u2013927.","journal-title":"Bioconjugate Chemistry"},{"key":"821_CR53","first-page":"585","volume":"7","author":"NM Sakhrani","year":"2013","unstructured":"Sakhrani, N. M., & Padh, H. (2013). Organelle targeting: Third level of drug targeting. Drug Design, Development and Therapy, 7, 585.","journal-title":"Drug Design, Development and Therapy"},{"key":"821_CR54","first-page":"539","volume-title":"Exosome Mediated Delivery of Functional Nucleic Acid Nanoparticles (NANPs)","author":"S Nordmeier","year":"2021","unstructured":"Nordmeier, S., Ke, W., Afonin, K. A., & Portnoy, V. (2021). Exosome Mediated Delivery of Functional Nucleic Acid Nanoparticles (NANPs) (pp. 539\u2013564). Jenny Stanford Publishing."},{"key":"821_CR55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119087","volume":"269","author":"EB Yahya","year":"2021","unstructured":"Yahya, E. B., & Alqadhi, A. M. (2021). Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sciences, 269, 119087.","journal-title":"Life Sciences"},{"key":"821_CR56","first-page":"10","volume":"101","author":"A Zhang","year":"2022","unstructured":"Zhang, A., Wang, Q., Liu, M., Tan, M., Zhang, X., & Wu, R. (2022). Efficacy and safety of Mudan granules for painful diabetic peripheral neuropathy: A protocol for a double-blind randomized controlled trial. Medicine, 101, 10.","journal-title":"Medicine"},{"issue":"8","key":"821_CR57","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","volume":"30","author":"DE Sabatino","year":"2022","unstructured":"Sabatino, D. E., Chair, F. D. B., Chandler, R. J., Crystal, R. G., Davidson, B. L., Dolmetsch, R., et al. (2022). Evaluating the state of the science for adeno-associated virus (AAV) Integration: An integrated perspective. Molecular Therapy, 30(8), 2646\u20132663.","journal-title":"Molecular Therapy"},{"issue":"9","key":"821_CR58","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.3390\/ijms22094534","volume":"22","author":"W Chiu","year":"2021","unstructured":"Chiu, W., Lin, T.-Y., Chang, Y.-C., Isahwan-Ahmad Mulyadi Lai, H., Lin, S.-C., Ma, C., et al. (2021). An update on gene therapy for inherited retinal dystrophy: experience in Leber congenital amaurosis clinical trials. International Journal of Molecular Sciences, 22(9), 4534.","journal-title":"International Journal of Molecular Sciences"},{"key":"821_CR59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.33597\/jcpt-03-id1028","volume":"3","author":"C Kim","year":"2022","unstructured":"Kim, C., Shim, H. S., Chang, Y., Im, H., & Yoo, J. (2022). Novel gene therapies technology for spinal cord injury (SCI) therapy: Efficient direct lineage reprogramming. Journal of Clinical Pharmacology and Therapeutics, 3, 29\u201333.","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"issue":"19","key":"821_CR60","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.3390\/ijms221910672","volume":"22","author":"O Franzese","year":"2021","unstructured":"Franzese, O., Torino, F., Giannetti, E., Cioccoloni, G., Aquino, A., Faraoni, I., et al. (2021). Abscopal effect and drug-induced xenogenization: A strategic alliance in cancer treatment? International journal of molecular sciences., 22(19), 10672.","journal-title":"International journal of molecular sciences."},{"issue":"1","key":"821_CR61","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10258","volume":"7","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022). Viral vector-based gene therapies in the clinic. Bioengineering & Translational Medicine, 7(1), e10258.","journal-title":"Bioengineering & Translational Medicine"},{"issue":"2","key":"821_CR62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4236\/ym.2021.52011","volume":"5","author":"W Cai","year":"2021","unstructured":"Cai, W., Zhang, Y., Huang, Q., Xiang, Y., & Xin, H. (2021). Oncolytic engineering of ICP34.5 and LAT of herpes simplex virus type 1. Yangtze Medicine, 5(2), 106\u2013116.","journal-title":"Yangtze Medicine"},{"issue":"12","key":"821_CR63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1039\/C5BM00198F","volume":"3","author":"MA Islam","year":"2015","unstructured":"Islam, M. A., Reesor, E. K., Xu, Y., Zope, H. R., Zetter, B. R., & Shi, J. (2015). Biomaterials for mRNA delivery. Biomaterials Science, 3(12), 1519\u20131533.","journal-title":"Biomaterials Science"},{"issue":"12","key":"821_CR64","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1039\/C7BM00712D","volume":"5","author":"Z Meng","year":"2017","unstructured":"Meng, Z., O\u2019Keeffe-Ahern, J., Lyu, J., Pierucci, L., Zhou, D., & Wang, W. (2017). A new developing class of gene delivery: Messenger RNA-based therapeutics. Biomaterials Science, 5(12), 2381\u20132392.","journal-title":"Biomaterials Science"},{"key":"821_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/764706","volume":"2013","author":"K Saga","year":"2013","unstructured":"Saga, K., & Kaneda, Y. (2013). Virosome presents multimodel cancer therapy without viral replication. BioMed Research International, 2013, 1\u20139.","journal-title":"BioMed Research International"},{"issue":"1","key":"821_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-01635-1","volume":"7","author":"G Verlengia","year":"2017","unstructured":"Verlengia, G., Miyagawa, Y., Ingusci, S., Cohen, J. B., Simonato, M., & Glorioso, J. C. (2017). Engineered HSV vector achieves safe long-term transgene expression in the central nervous system. Scientific Reports, 7(1), 1\u201311.","journal-title":"Scientific Reports"},{"issue":"8","key":"821_CR67","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/jcp.26514","volume":"233","author":"N Hosseinahli","year":"2018","unstructured":"Hosseinahli, N., Aghapour, M., Duijf, P. H., & Baradaran, B. (2018). Treating cancer with microRNA replacement therapy: A literature review. Journal of Cellular Physiology, 233(8), 5574\u20135588.","journal-title":"Journal of Cellular Physiology"},{"issue":"9","key":"821_CR68","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","volume":"52","author":"JA Kulkarni","year":"2019","unstructured":"Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R., & van der Meel, R. (2019). Lipid nanoparticle technology for clinical translation of siRNA therapeutics. Accounts of Chemical Research, 52(9), 2435\u20132444.","journal-title":"Accounts of Chemical Research"},{"issue":"6","key":"821_CR69","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2007.06.015","volume":"47","author":"T Watanabe","year":"2007","unstructured":"Watanabe, T., Umehara, T., Yasui, F., Nakagawa, S.-I., Yano, J., Ohgi, T., et al. (2007). Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. Journal of Hepatology, 47(6), 744\u2013750.","journal-title":"Journal of Hepatology"},{"issue":"3","key":"821_CR70","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jconrel.2013.08.300","volume":"172","author":"M Kullberg","year":"2013","unstructured":"Kullberg, M., McCarthy, R., & Anchordoquy, T. J. (2013). Systemic tumor-specific gene delivery. Journal of Controlled Release, 172(3), 730\u2013736.","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"821_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-023-02253-y","volume":"19","author":"K Wang","year":"2021","unstructured":"Wang, K., Shang, F., Chen, D., Cao, T., Wang, X., Jiao, J., et al. (2021). Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy. Journal of Nanobiotechnology, 19(1), 1\u201315.","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"821_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"L Miao","year":"2020","unstructured":"Miao, L., Lin, J., Huang, Y., Li, L., Delcassian, D., Ge, Y., et al. (2020). Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nature Communications, 11(1), 1\u201313.","journal-title":"Nature Communications"},{"issue":"1","key":"821_CR73","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2011.10.031","volume":"158","author":"AJ Kim","year":"2012","unstructured":"Kim, A. J., Boylan, N. J., Suk, J. S., Lai, S. K., & Hanes, J. (2012). Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles. Journal of Controlled Release, 158(1), 102\u2013107.","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"821_CR74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.actbio.2010.08.003","volume":"7","author":"C Greulich","year":"2011","unstructured":"Greulich, C., Diendorf, J., Simon, T., Eggeler, G., Epple, M., & K\u00f6ller, M. (2011). Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomaterialia, 7(1), 347\u2013354.","journal-title":"Acta Biomaterialia"},{"issue":"12","key":"821_CR75","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021). Lipid nanoparticles for mRNA delivery. Nature Reviews Materials, 6(12), 1078\u20131094.","journal-title":"Nature Reviews Materials"},{"issue":"1","key":"821_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01335-5","volume":"20","author":"L Miao","year":"2021","unstructured":"Miao, L., Zhang, Y., & Huang, L. (2021). mRNA vaccine for cancer immunotherapy. Molecular Cancer, 20(1), 1\u201323.","journal-title":"Molecular Cancer"},{"key":"821_CR77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","volume":"170","author":"J Kim","year":"2021","unstructured":"Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021). Self-assembled mRNA vaccines. Advanced Drug Delivery Reviews, 170, 83\u2013112.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"821_CR78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/vaccines9060540","volume":"9","author":"T Imai","year":"2021","unstructured":"Imai, T. (2021). Single amino acid deletion at n-terminus of the target antigen in DNA vaccine induces altered CD8+ T cell responses against tumor antigen. Vaccines, 9(6), 540.","journal-title":"Vaccines"},{"issue":"8","key":"821_CR79","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41557-022-00972-7","volume":"14","author":"N Kl\u00f6cker","year":"2022","unstructured":"Kl\u00f6cker, N., Weissenboeck, F. P., van D\u00fclmen, M., \u0160pa\u010dek, P., H\u00fcwel, S., & Rentmeister, A. (2022). Photocaged 5\u2032 cap analogues for optical control of mRNA translation in cells. Nature Chemistry, 14(8), 905\u2013913.","journal-title":"Nature Chemistry"},{"key":"821_CR80","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-031-08415-7_9","volume-title":"Messenger RNA Therapeutics","author":"S-H Chan","year":"2022","unstructured":"Chan, S.-H., & Roy, B. (2022). Preparation of synthetic mRNAs\u2014Overview and considerations. In S. Jurga & J. Barciszewski (Eds.), Messenger RNA Therapeutics (pp. 181\u2013207). Springer."},{"issue":"2","key":"821_CR81","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.39","volume":"1","author":"JM Henderson","year":"2021","unstructured":"Henderson, J. M., Ujita, A., Hill, E., Yousif-Rosales, S., Smith, C., Ko, N., et al. (2021). Cap 1 messenger RNA synthesis with co-transcriptional CleanCap\u00ae analog by in vitro transcription. Current protocols., 1(2), e39.","journal-title":"Current protocols."},{"key":"821_CR82","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151513","author":"L Babin","year":"2021","unstructured":"Babin, L., Andraos, E., Fuchs, S., Pyronnet, S., Brunet, E., & Meggetto, F. (2021). From circRNAs to fusion circRNAs in hematological malignancies. JCI insight. https:\/\/doi.org\/10.1172\/jci.insight.151513","journal-title":"JCI insight"},{"issue":"37","key":"821_CR83","doi-asserted-by":"crossref","first-page":"15120","DOI":"10.1021\/jacs.1c05214","volume":"143","author":"T Hagen","year":"2021","unstructured":"Hagen, T., Laski, A., Br\u00fcmmer, A., Pruska, A., Schl\u00f6sser, V., Clery, A., et al. (2021). Inosine substitutions in RNA activate latent G-quadruplexes. Journal of the American Chemical Society, 143(37), 15120\u201315130.","journal-title":"Journal of the American Chemical Society"},{"issue":"3","key":"821_CR84","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrm.2017.103","volume":"19","author":"K Leppek","year":"2018","unstructured":"Leppek, K., Das, R., & Barna, M. (2018). Functional 5\u2032 UTR mRNA structures in eukaryotic translation regulation and how to find them. Nature Reviews Molecular Cell Biology, 19(3), 158\u2013174.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"821_CR85","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-0716-1374-0_20","volume-title":"RNA Modifications","author":"B Roy","year":"2021","unstructured":"Roy, B. (2021). Effects of mRNA modifications on translation: An overview. In M. McMahon (Ed.), RNA Modifications (pp. 327\u2013356). Springer."},{"issue":"4","key":"821_CR86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","volume":"22","author":"NA Lind","year":"2022","unstructured":"Lind, N. A., Rael, V. E., Pestal, K., Liu, B., & Barton, G. M. (2022). Regulation of the nucleic acid-sensing Toll-like receptors. Nature Reviews Immunology, 22(4), 224\u2013235.","journal-title":"Nature Reviews Immunology"},{"key":"821_CR87","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.omtn.2018.06.010","volume":"12","author":"S Vaidyanathan","year":"2018","unstructured":"Vaidyanathan, S., Azizian, K. T., Haque, A. A., Henderson, J. M., Hendel, A., Shore, S., et al. (2018). Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification. Molecular Therapy-Nucleic Acids, 12, 530\u2013542.","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"1","key":"821_CR88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/vaccines9010065","volume":"9","author":"MD Buschmann","year":"2021","unstructured":"Buschmann, M. D., Carrasco, M. J., Alishetty, S., Paige, M., Alameh, M. G., & Weissman, D. (2021). Nanomaterial delivery systems for mRNA vaccines. Vaccines, 9(1), 65.","journal-title":"Vaccines"},{"issue":"16","key":"821_CR89","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"SS Rosa","year":"2021","unstructured":"Rosa, S. S., Prazeres, D. M., Azevedo, A. M., & Marques, M. P. (2021). mRNA vaccines manufacturing: Challenges and bottlenecks. Vaccine, 39(16), 2190\u20132200.","journal-title":"Vaccine"},{"issue":"3","key":"821_CR90","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/pharmaceutics14030512","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Zhang, R., Tang, L., & Yang, L. (2022). Nonviral delivery systems of mRNA vaccines for cancer gene therapy. Pharmaceutics, 14(3), 512.","journal-title":"Pharmaceutics"},{"issue":"5","key":"821_CR91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","volume":"7","author":"AM Reichmuth","year":"2016","unstructured":"Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016). mRNA vaccine delivery using lipid nanoparticles. Therapeutic Delivery, 7(5), 319\u2013334.","journal-title":"Therapeutic Delivery"},{"key":"821_CR92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","volume":"174","author":"L Barile","year":"2017","unstructured":"Barile, L., & Vassalli, G. (2017). Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacology & Therapeutics, 174, 63\u201378.","journal-title":"Pharmacology & Therapeutics"},{"key":"821_CR93","doi-asserted-by":"crossref","first-page":"761362","DOI":"10.3389\/fmed.2021.761362","volume":"8","author":"W Chiangjong","year":"2021","unstructured":"Chiangjong, W., Netsirisawan, P., Hongeng, S., & Chutipongtanate, S. (2021). Red blood cell extracellular vesicle-based drug delivery: Challenges and opportunities. Frontiers in Medicine, 8, 761362.","journal-title":"Frontiers in Medicine"},{"issue":"3","key":"821_CR94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","volume":"28","author":"K Bloom","year":"2021","unstructured":"Bloom, K., van den Berg, F., & Arbuthnot, P. (2021). Self-amplifying RNA vaccines for infectious diseases. Gene Therapy, 28(3), 117\u2013129.","journal-title":"Gene Therapy"},{"key":"821_CR95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","volume":"131","author":"EH Pilkington","year":"2021","unstructured":"Pilkington, E. H., Suys, E. J., Trevaskis, N. L., Wheatley, A. K., Zukancic, D., Algarni, A., et al. (2021). From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomaterialia, 131, 16\u201340.","journal-title":"Acta Biomaterialia"},{"key":"821_CR96","volume-title":"Formulation and Delivery Technologies for mRNA Vaccines","author":"C Zeng","year":"2020","unstructured":"Zeng, C., Zhang, C., Walker, P. G., & Dong, Y. (2020). Formulation and Delivery Technologies for mRNA Vaccines. Springer."},{"key":"821_CR97","doi-asserted-by":"crossref","first-page":"101923","DOI":"10.1016\/j.jbc.2022.101923","volume":"71","author":"E Grellet","year":"2022","unstructured":"Grellet, E., Goulet, A., & Imbert, I. (2022). Replication of the coronavirus genome: A paradox among positive-strand RNA viruses. Journal of Biological Chemistry, 71, 101923.","journal-title":"Journal of Biological Chemistry"},{"key":"821_CR98","first-page":"2648","volume":"12","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S.-S. (2021). From COVID-19 to cancer mRNA vaccines: Moving from bench to clinic in the vaccine landscape. Frontiers in Immunology, 12, 2648.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"821_CR99","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.immuni.2021.07.017","volume":"54","author":"K Bok","year":"2021","unstructured":"Bok, K., Sitar, S., Graham, B. S., & Mascola, J. R. (2021). Accelerated COVID-19 vaccine development: Milestones, lessons, and prospects. Immunity, 54(8), 1636\u20131651.","journal-title":"Immunity"},{"key":"821_CR100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.addr.2021.05.018","volume":"174","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Wang, S., Tapeinos, C., Torrieri, G., K\u00e4nk\u00e4nen, V., El-Sayed, N., et al. (2021). Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines. Advanced Drug Delivery Reviews, 174, 576\u2013612.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"821_CR101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fsufs.2019.00023","volume":"3","author":"P Akuma","year":"2019","unstructured":"Akuma, P., Okagu, O. D., & Udenigwe, C. C. (2019). Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Frontiers in Sustainable Food Systems, 3, 23.","journal-title":"Frontiers in Sustainable Food Systems"},{"key":"821_CR102","volume":"176","author":"W Ke","year":"2021","unstructured":"Ke, W., & Afonin, K. A. (2021). Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs). Advanced Drug Delivery Reviews, 176, 113835.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"821_CR103","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.celrep.2013.10.019","volume":"5","author":"L Abrami","year":"2013","unstructured":"Abrami, L., Brandi, L., Moayeri, M., Brown, M. J., Krantz, B. A., Leppla, S. H., et al. (2013). Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin. Cell Reports, 5(4), 986\u2013996.","journal-title":"Cell Reports"},{"key":"821_CR104","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1473-3099(23)00013-0","volume":"23","author":"KIRBY, T.","year":"2023","unstructured":"KIRBY, T. (2023). mRNA vaccine technology for a multivalent flu vaccine. The Lancet Infectious Diseases, 23, 157.","journal-title":"The Lancet Infectious Diseases"},{"key":"821_CR105","doi-asserted-by":"crossref","first-page":"eadg1036","DOI":"10.1126\/sciadv.adg1036","volume":"9","author":"E Kon","year":"2023","unstructured":"Kon, E., Levy, Y., Elia, U., Cohen, H., Hazan-Halevy, I., Aftalion, M., Ezra, A., Bar-Haim, E., Naidu, G. S., & Diesendruck, Y. (2023). A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances, 9, eadg1036.","journal-title":"Science Advances"},{"issue":"11","key":"821_CR106","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","volume":"28","author":"X Huang","year":"2022","unstructured":"Huang, X., Kong, N., Zhang, X., Cao, Y., & Langer, R. (2022). The landscape of mRNA nanomedicine. Nature Medicine, 28(11), 2273\u20132287.","journal-title":"Nature Medicine"},{"issue":"24","key":"821_CR107","first-page":"107","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes, B. B., Conniot, J., Avital, A., Yao, D., Jiang, X., Zhou, X., Sharf-Pauker, N., Xiao, Y., Adir, O., & Liang, H. (2022). Nanodelivery of nucleic acids. Nature Reviews Methods Primers, 2(24), 107.","journal-title":"Nature Reviews Methods Primers"},{"key":"821_CR108","volume":"7","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022). Viral vector-based gene therapies in the clinic. Bioengineering & Translational Medicine, 7, e10258.","journal-title":"Bioengineering & Translational Medicine"},{"key":"821_CR109","doi-asserted-by":"crossref","first-page":"2206187","DOI":"10.1002\/advs.202206187","volume":"10","author":"M Nawaz","year":"2023","unstructured":"Nawaz, M., Heydarkhan-Hagvall, S., Tangruksa, B., Gonz\u00e1lez-King Garibotti, H., Jing, Y., Maugeri, M., Kohl, F., Hultin, L., Reyahi, A., & Camponeschi, A. (2023). Lipid nanoparticles deliver the therapeutic VEGFA mRNA in vitro and in vivo and transform extracellular vesicles for their functional extensions. Advanced Science, 10, 2206187.","journal-title":"Advanced Science"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:12:28Z","timestamp":1722028348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":109,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00821-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}